This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMDGW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $8,854.78 and a completion date of December 4, 2024.
The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor with a significant presence in federal healthcare procurement, Amerisourcebergen plays a critical role in supplying medical products to various military and veterans' healthcare systems through its extensive supply chain and distribution capabilities.
Generated 3/4/25, 11:10 AM